Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Improvement of gelatin particle agglutination test for detection of anti-HTLV-I antibody.

Literature DB >> 1904415

Improvement of gelatin particle agglutination test for detection of anti-HTLV-I antibody.

R Fujino¹, K Kawato, M Ikeda, H Miyakoshi, M Mizukoshi, J Imai.

Abstract

Partial modifications of antigen components were made to improve the gelatin particle agglutination (PA) test for the detection of antibodies against human T cell leukemia virus type-I. Envelope glycoproteins prepared by lentil lectin affinity chromatography were further added to the purified viral antigens to be coated on the gelatin particles. Comparative studies with a conventional PA test kit (Serodia ATLA) and indirect immunofluorescence assay showed that the specificity and sensitivity of the new PA test were increased and that abnormal agglutination such as the prozone phenomenon was abolished by this improvement.

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 1991 PMID： 1904415 PMCID： PMC5918434 DOI： 10.1111/j.1349-7006.1991.tb01856.x

Source DB: PubMed Journal: Jpn J Cancer Res ISSN： 0910-5050

human T cell leukemia virus type‐I adult T cell leukemia enzyme‐linked immuno‐sorbent assay indirect immunofluorescence particle agglutination western blot

28 in total

1. Comparative diagnostic assay results for detecting antibody to HTLV-I in Japanese blood donor samples: higher positivity rates by particle agglutination assay [corrected].

Authors: J Ishizaki; A Okayama; N Tachibana; T Yokota; E Shishime; K Tsuda; N Mueller
Journal: J Acquir Immune Defic Syndr (1988) Date: 1988

2. Human retroviral env and gag polypeptides: serologic assays to measure infection.

Authors: S B Kanner; C Cheng-Mayer; R B Geffin; W P Parks; G A Beltz; L O Arthur; K P Samuel; T S Papas
Journal: J Immunol Date: 1986-07-15 Impact factor: 5.422

3. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.

Authors: T J Palker; M E Tanner; R M Scearce; R D Streilein; M E Clark; B F Haynes
Journal: J Immunol Date: 1989-02-01 Impact factor: 5.422

4. Adult T-cell leukemia-associated antigen (ATLA): detection of a glycoprotein in cell- and virus-free supernatant.

Authors: N Yamamoto; J Schneider; Y Hinuma; G Hunsmann
Journal: Z Naturforsch C Biosci Date: 1982 Jul-Aug

5. Milk-borne transmission of HTLV-I from carrier mothers to their children.

Authors: K Kinoshita; T Amagasaki; S Hino; H Doi; K Yamanouchi; N Ban; S Momita; S Ikeda; S Kamihira; M Ichimaru
Journal: Jpn J Cancer Res Date: 1987-07

6. A new agglutination test for serum antibodies to adult T-cell leukemia virus.

Authors: M Ikeda; R Fujino; T Matsui; T Yoshida; H Komoda; J Imai
Journal: Gan Date: 1984-10

7. Establishment of human cytotoxic T cell lines specific for human adult T cell leukemia virus-bearing cells.

Authors: M Kannagi; K Sugamura; H Sato; K Okochi; H Uchino; Y Hinuma
Journal: J Immunol Date: 1983-06 Impact factor: 5.422

8. The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group.

Authors: K Tajima
Journal: Int J Cancer Date: 1990-02-15 Impact factor: 7.396

9. Mother-to-child transmission of human T-cell leukemia virus type I (HTLV-I): a fifteen-year follow-up study in Okinawa, Japan.

Authors: K Kusuhara; S Sonoda; K Takahashi; K Tokugawa; J Fukushige; K Ueda
Journal: Int J Cancer Date: 1987-12-15 Impact factor: 7.396

10. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors: B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal: Proc Natl Acad Sci U S A Date: 1980-12 Impact factor: 11.205

17 in total

1. Improvement of simultaneous detection of antibodies to Gag and envelope antigens of human T-lymphotropic virus type I by western immunoblot assay.

Authors: H Miyakoshi; M Sugimoto; H Igarashi; H Honda; R Fujino; M Mizukoshi
Journal: J Clin Microbiol Date: 1992-10 Impact factor: 5.948

2. Rapid, sensitive, specific, and quantitative detection of human T-cell leukemia virus type 1 sequence in peripheral blood mononuclear cells by an improved polymerase chain reaction method with nested primers.

Authors: Y Aono; J Imai; K Tominaga; S Orita; A Sato; H Igarashi
Journal: Virus Genes Date: 1992-04 Impact factor: 2.332

3. High frequencies of human T-lymphotropic virus type I (HTLV-I) infection and presence of HTLV-II proviral DNA in blood donors with anti-thyroid antibodies.

Authors: H Mine; H Kawai; K Yokoi; M Akaike; S Saito
Journal: J Mol Med (Berl) Date: 1996-08 Impact factor: 4.599

4. Use of dried blood spots for the detection and confirmation of HTLV-I specific antibodies for epidemiological purposes.

Authors: S P Parker; M B Taylor; A E Ades; W D Cubitt; C Peckham
Journal: J Clin Pathol Date: 1995-10 Impact factor: 3.411

5. Expression of human T lymphotropic virus type 1 (HTLV-1) tax/rex gene in fresh bronchoalveolar lavage cells of HTLV-1-infected individuals.

Authors: Y Higashiyama; S Katamine; S Kohno; H Mukae; S Hino; T Miyamoto; K Hara
Journal: Clin Exp Immunol Date: 1994-05 Impact factor: 4.330

6. Trypsin-sensitive and -resistant components in human T-cell membranes required for syncytium formation by human T-cell lymphotropic virus type 1-bearing cells.

Authors: Y Sagara; C Ishida; Y Inoue; H Shiraki; Y Maeda
Journal: J Virol Date: 1997-01 Impact factor: 5.103

10. Inhibitory activity in saliva of cell-to-cell transmission of human T-cell lymphotropic virus type 1 in vitro: evaluation of saliva as an alternative source of transmission.

Authors: T Yamamoto; K Terada; N Nishida; R Moriuchi; S Shirabe; T Nakamura; Y Tsuji; T Miyamoto; S Katamine
Journal: J Clin Microbiol Date: 1995-06 Impact factor: 5.948